Half Year Full Year Movement Revenue 54,483 100,847 46,364 Other income 148,460 177,193 28,733 Interest revenue calculated using the effective interest method 13,915 26,175 12,260 216,858 304,215 87,357 Expenses Employee benefits expense -253,065 -282,658 -29,593 Administration expenses -299,179 -210,360 88,819 Depreciation and amortisation expense -7,910 -7,910 - Advertising and marketing expenses -49,676 -68,837 -19,161 Professional and consulting expenses -235,119 -678,907 -443,788 Impairment of Receivables - -7,150 -7,150 Other expenses -26,121 -41,975 -15,854 Total Expenses -871,070 -1,297,797 -426,727 Loss before income tax expense -654,212 -993,582 -339,370
* what are the professional and consulting expenses? Looks like administration expenses have been moved to professional and consulting expenses. Otherwise, losses/costs are down.
This is a cheap shell. If Loyyal can be sold for anything near its cost, then this thing has hope. Just needs some new directors and out with the old.
I hear that some changes are in the wind..
- Forums
- ASX - By Stock
- 1TT
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-10
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1TT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $611.6K |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 15726440 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 36004211 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 15716440 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 36004211 | 25 |
0.003 | 47622580 | 15 |
0.004 | 2865000 | 8 |
0.005 | 1090204 | 4 |
0.006 | 3000000 | 1 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
1TT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online